Evista

Evista (Raloxifene Hydrochloride) is a medication used to treat and prevent osteoporosis in postmenopausal women. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs).

Evista is primarily used to prevent and treat osteoporosis in postmenopausal women. It works by mimicking the effects of estrogen in some tissues, such as bones, to maintain bone density and reduce the risk of fractures. Evista is also used to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk for the disease. The medication is not intended for use in men or premenopausal women.

Common effects of Evista may include hot flashes, leg cramps, and swelling in the legs. Some users may also experience flu-like symptoms, joint pain, or sweating. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Evista should be used with caution in individuals with a history of blood clots or conditions that increase the risk of blood clots. It is important to inform your healthcare provider about any medical conditions or allergies before starting Evista. Regular monitoring may be required to ensure the medication is working effectively and to manage any potential side effects.

Evista may interact with other medications, including cholesterol-lowering drugs, blood thinners, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using Evista, as it may increase the risk of certain side effects.